Cite
HARVARD Citation
Lataillade, M. et al. (2020). Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study. Lancet. 7 (11), pp. e740-e751. [Online].